| . | Whole group (n = 100) . | Sham RIC (n = 47) . | RIC (n = 53) . | P-value . |
|---|---|---|---|---|
| Haemoglobin (g/L) | 138 ± 19 | 136 ± 19 | 139 ± 19 | 0.400 |
| Haematocrit (%) | 41 ± 6 | 40 ± 6 | 41 ± 5 | 0.516 |
| Neutrophil count (×109/L) | 8.6 ± 2.9 | 8.6 ± 2.8 | 8.6 ± 3.1 | 0.938 |
| Platelet count (×109/L) | 259 ± 77 | 258 ± 78 | 260 ± 77 | 0.923 |
| Serum albumin (g/L)a | 43 ± 3.7 | 42 ± 3.8 | 43 ± 3.7 | 0.243 |
| Sodium (mmol/L) | 138 ± 3 | 138 ± 2 | 138 ± 3 | 0.789 |
| Creatinine (µmol/L) | 91 ± 37 | 94 ± 49 | 89 ± 23 | 0.513 |
| Peak troponin T (ng/L)a | 2223 (1072–3796) | 2014 (993–3606) | 2301 (1074–3945) | 0.474 |
| Fibrinogen (g/L) | 4.6 ± 1.3 | 4.6 ± 1.1 | 4.7 ± 1.5 | 0.605 |
| PT (s) | 11.8 ± 1.1 | 11.8 ± 1.0 | 11.9 ± 1.2 | 0.728 |
| aPTT (s) | 28.1 ± 3.6 | 27.5 ± 3.4 | 28.6 ± 3.7 | 0.175 |
| Total cholesterol (mmol/L) | 5.1 ± 1.2 | 4.9 ± 1.2 | 5.3 ± 1.1 | 0.121 |
| LDL cholesterol (mmol/L) | 2.9 ± 0.8 | 2.9 ± 0.9 | 2.9 ± 0.7 | 0.867 |
| Hs C-reactive protein (mg/L)a | 3 (1–8) | 3 (2–8) | 2 (1–8) | 0.273 |
| . | Whole group (n = 100) . | Sham RIC (n = 47) . | RIC (n = 53) . | P-value . |
|---|---|---|---|---|
| Haemoglobin (g/L) | 138 ± 19 | 136 ± 19 | 139 ± 19 | 0.400 |
| Haematocrit (%) | 41 ± 6 | 40 ± 6 | 41 ± 5 | 0.516 |
| Neutrophil count (×109/L) | 8.6 ± 2.9 | 8.6 ± 2.8 | 8.6 ± 3.1 | 0.938 |
| Platelet count (×109/L) | 259 ± 77 | 258 ± 78 | 260 ± 77 | 0.923 |
| Serum albumin (g/L)a | 43 ± 3.7 | 42 ± 3.8 | 43 ± 3.7 | 0.243 |
| Sodium (mmol/L) | 138 ± 3 | 138 ± 2 | 138 ± 3 | 0.789 |
| Creatinine (µmol/L) | 91 ± 37 | 94 ± 49 | 89 ± 23 | 0.513 |
| Peak troponin T (ng/L)a | 2223 (1072–3796) | 2014 (993–3606) | 2301 (1074–3945) | 0.474 |
| Fibrinogen (g/L) | 4.6 ± 1.3 | 4.6 ± 1.1 | 4.7 ± 1.5 | 0.605 |
| PT (s) | 11.8 ± 1.1 | 11.8 ± 1.0 | 11.9 ± 1.2 | 0.728 |
| aPTT (s) | 28.1 ± 3.6 | 27.5 ± 3.4 | 28.6 ± 3.7 | 0.175 |
| Total cholesterol (mmol/L) | 5.1 ± 1.2 | 4.9 ± 1.2 | 5.3 ± 1.1 | 0.121 |
| LDL cholesterol (mmol/L) | 2.9 ± 0.8 | 2.9 ± 0.9 | 2.9 ± 0.7 | 0.867 |
| Hs C-reactive protein (mg/L)a | 3 (1–8) | 3 (2–8) | 2 (1–8) | 0.273 |
Values are represented as mean ± standard deviation, except awhere values are represented as median (interquartile range).
All values measured at presentation, except peak troponin T.
Normal values: haemoglobin 130–180 g/L (males) and 115–165 g/L (females); haematocrit 40–52% (males) and 36–47% (females); neutrophil count 2–7.5 ×109/L; platelet count 150–400 ×109/L; serum albumin 34–54 g/L; serum sodium 135–145 mmol/L, creatinine 60–110 μmol/L (males), and 45-90 μmol/L (females); troponin T < 14 ng/L (Elecsys high-sensitivity assay, Roche Diagnostics); fibrinogen 2–4 g/L; PT 11–13.5 s; aPTT 25–35 s; total cholesterol ≤4.0 mmol/L; LDL cholesterol ≤2.0 mmol/L; high-sensitivity C-reactive protein 0–3 mg/L.
aPTT, activated partial thromboplastin time; LDL, low-density lipoprotein; PT, prothrombin time.
| . | Whole group (n = 100) . | Sham RIC (n = 47) . | RIC (n = 53) . | P-value . |
|---|---|---|---|---|
| Haemoglobin (g/L) | 138 ± 19 | 136 ± 19 | 139 ± 19 | 0.400 |
| Haematocrit (%) | 41 ± 6 | 40 ± 6 | 41 ± 5 | 0.516 |
| Neutrophil count (×109/L) | 8.6 ± 2.9 | 8.6 ± 2.8 | 8.6 ± 3.1 | 0.938 |
| Platelet count (×109/L) | 259 ± 77 | 258 ± 78 | 260 ± 77 | 0.923 |
| Serum albumin (g/L)a | 43 ± 3.7 | 42 ± 3.8 | 43 ± 3.7 | 0.243 |
| Sodium (mmol/L) | 138 ± 3 | 138 ± 2 | 138 ± 3 | 0.789 |
| Creatinine (µmol/L) | 91 ± 37 | 94 ± 49 | 89 ± 23 | 0.513 |
| Peak troponin T (ng/L)a | 2223 (1072–3796) | 2014 (993–3606) | 2301 (1074–3945) | 0.474 |
| Fibrinogen (g/L) | 4.6 ± 1.3 | 4.6 ± 1.1 | 4.7 ± 1.5 | 0.605 |
| PT (s) | 11.8 ± 1.1 | 11.8 ± 1.0 | 11.9 ± 1.2 | 0.728 |
| aPTT (s) | 28.1 ± 3.6 | 27.5 ± 3.4 | 28.6 ± 3.7 | 0.175 |
| Total cholesterol (mmol/L) | 5.1 ± 1.2 | 4.9 ± 1.2 | 5.3 ± 1.1 | 0.121 |
| LDL cholesterol (mmol/L) | 2.9 ± 0.8 | 2.9 ± 0.9 | 2.9 ± 0.7 | 0.867 |
| Hs C-reactive protein (mg/L)a | 3 (1–8) | 3 (2–8) | 2 (1–8) | 0.273 |
| . | Whole group (n = 100) . | Sham RIC (n = 47) . | RIC (n = 53) . | P-value . |
|---|---|---|---|---|
| Haemoglobin (g/L) | 138 ± 19 | 136 ± 19 | 139 ± 19 | 0.400 |
| Haematocrit (%) | 41 ± 6 | 40 ± 6 | 41 ± 5 | 0.516 |
| Neutrophil count (×109/L) | 8.6 ± 2.9 | 8.6 ± 2.8 | 8.6 ± 3.1 | 0.938 |
| Platelet count (×109/L) | 259 ± 77 | 258 ± 78 | 260 ± 77 | 0.923 |
| Serum albumin (g/L)a | 43 ± 3.7 | 42 ± 3.8 | 43 ± 3.7 | 0.243 |
| Sodium (mmol/L) | 138 ± 3 | 138 ± 2 | 138 ± 3 | 0.789 |
| Creatinine (µmol/L) | 91 ± 37 | 94 ± 49 | 89 ± 23 | 0.513 |
| Peak troponin T (ng/L)a | 2223 (1072–3796) | 2014 (993–3606) | 2301 (1074–3945) | 0.474 |
| Fibrinogen (g/L) | 4.6 ± 1.3 | 4.6 ± 1.1 | 4.7 ± 1.5 | 0.605 |
| PT (s) | 11.8 ± 1.1 | 11.8 ± 1.0 | 11.9 ± 1.2 | 0.728 |
| aPTT (s) | 28.1 ± 3.6 | 27.5 ± 3.4 | 28.6 ± 3.7 | 0.175 |
| Total cholesterol (mmol/L) | 5.1 ± 1.2 | 4.9 ± 1.2 | 5.3 ± 1.1 | 0.121 |
| LDL cholesterol (mmol/L) | 2.9 ± 0.8 | 2.9 ± 0.9 | 2.9 ± 0.7 | 0.867 |
| Hs C-reactive protein (mg/L)a | 3 (1–8) | 3 (2–8) | 2 (1–8) | 0.273 |
Values are represented as mean ± standard deviation, except awhere values are represented as median (interquartile range).
All values measured at presentation, except peak troponin T.
Normal values: haemoglobin 130–180 g/L (males) and 115–165 g/L (females); haematocrit 40–52% (males) and 36–47% (females); neutrophil count 2–7.5 ×109/L; platelet count 150–400 ×109/L; serum albumin 34–54 g/L; serum sodium 135–145 mmol/L, creatinine 60–110 μmol/L (males), and 45-90 μmol/L (females); troponin T < 14 ng/L (Elecsys high-sensitivity assay, Roche Diagnostics); fibrinogen 2–4 g/L; PT 11–13.5 s; aPTT 25–35 s; total cholesterol ≤4.0 mmol/L; LDL cholesterol ≤2.0 mmol/L; high-sensitivity C-reactive protein 0–3 mg/L.
aPTT, activated partial thromboplastin time; LDL, low-density lipoprotein; PT, prothrombin time.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
